Mangalam Drugs and Organics share news, announcements and annual reports
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Mangalam Drugs and Organics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2005
Last close ₹28.61down ₹0.61 (2.09%)BSE ₹28.92
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.22.
30 Oct: open ₹29.48, high ₹29.75, low ₹28.51
52-week range of traded prices to 30 Oct 2026
₹22.80Low, 29 Dec 2025₹68.40High, 30 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 50,07391.9% delivered
Mangalam Drugs and Organics board and management
41 filed, newest first.
Sep 2026
Aug 2026
12 Aug · Management
Apr 2026
Jan 2026
17 Jan · Management
Dec 2025
Sep 2025
Apr 2025
Mar 2025
29 Mar · Management
Aug 2024
13 Aug · Management
Jul 2024
Jun 2024
27 Jun · Management
Aug 2022
Mar 2022
Feb 2022
Sep 2021
27 Sep · Management
27 Sep · Management
Aug 2021
12 Aug · Management
Jul 2021
6 Jul · Management
Jun 2021
9 Jun · Management
Mar 2021
21 Mar · Management
Dec 2020
Nov 2020
Jul 2019
8 Jul · Management
Apr 2019
16 Apr · Management
Aug 2018
14 Aug · Management
May 2018
28 May · Management
Nov 2017
20 Nov · Management
May 2016
Sep 2015
May 2015
Feb 2015
5 Feb · Management
Mr. Rajendra Prasad Mimani has resigned as Director from the Board of the Company. The resignation is effective from February 3, 2015.
Oct 2014
27 Oct · Management
Mrs. Meenal Sukhani has been appointed as Additional Director on the Board of the Company w.e.f. October 21, 2014. She will be Non - Executive Director of the Company.
May 2010
29 May · Management
At the meeting of the Board of Directors of the Company held on May 29, 2010, Mr. Mukul Ajaykumar Sukhani has resigned as Director of the Company with effect from May 29, 2010.
Jul 2009
30 Jul · Management
Mr. Mukul Sukhani has been appointed as Additional Director on the Board of the Company with effect from July 27, 2009. He will be Independent and Non-Executive Director of the Company.